These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25511972)

  • 21. In Silico Approaches in Predictive Genetic Toxicology.
    Sinha M; Dhawan A; Parthasarathi R
    Methods Mol Biol; 2019; 2031():351-373. PubMed ID: 31473971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches for externally validated QSAR modelling of Nitrated Polycyclic Aromatic Hydrocarbon mutagenicity.
    Gramatica P; Pilutti P; Papa E
    SAR QSAR Environ Res; 2007; 18(1-2):169-78. PubMed ID: 17365967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Salmonella mutagenicity.
    Zeiger E; Ashby J; Bakale G; Enslein K; Klopman G; Rosenkranz HS
    Mutagenesis; 1996 Sep; 11(5):471-84. PubMed ID: 8921509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR modeling of genotoxic phenomena: the consequence on predictive performance of deviation from a unity ratio of genotoxicants/non-genotoxicants.
    Rosenkranz HS
    Mutat Res; 2004 Apr; 559(1-2):67-71. PubMed ID: 15066575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
    Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automatic knowledge extraction from chemical structures: the case of mutagenicity prediction.
    Ferrari T; Cattaneo D; Gini G; Golbamaki Bakhtyari N; Manganaro A; Benfenati E
    SAR QSAR Environ Res; 2013; 24(5):365-83. PubMed ID: 23710765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the OECD QSAR Application Toolbox and Toxtree for estimating the mutagenicity of chemicals. Part 1. Aromatic amines.
    Devillers J; Mombelli E
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):753-69. PubMed ID: 21120760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
    Contrera JF
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of mutagenicity and carcinogenicity using in silico modelling: A case study of polychlorinated biphenyls.
    Vračko M; Bobst S
    SAR QSAR Environ Res; 2015; 26(7-9):667-82. PubMed ID: 26329919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the OECD QSAR Application Toolbox and Toxtree for estimating the mutagenicity of chemicals. Part 2. α-β unsaturated aliphatic aldehydes.
    Devillers J; Mombelli E
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):771-83. PubMed ID: 21120761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topological structural alerts modulations of mammalian cell mutagenicity for halogenated derivatives.
    Pérez-Garrido A; Girón-Rodríguez F; Morales Helguera A; Borges F; Combes RD
    SAR QSAR Environ Res; 2014; 25(1):17-33. PubMed ID: 24283490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and application of (Q)SAR models to predict chemical-induced in vitro chromosome aberrations.
    Hsu CW; Hewes KP; Stavitskaya L; Kruhlak NL
    Regul Toxicol Pharmacol; 2018 Nov; 99():274-288. PubMed ID: 30278198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a method to assess the informational content of structure-activity data bases.
    Takihi N; Zhang YP; Klopman G; Rosenkranz HS
    Qual Assur; 1993 Sep; 2(3):255-64. PubMed ID: 8137086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
    Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Searching for an enhanced predictive tool for mutagenicity.
    Klopman G; Zhu H; Fuller MA; Saiakhov RD
    SAR QSAR Environ Res; 2004 Aug; 15(4):251-63. PubMed ID: 15370416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2022; 2425():149-183. PubMed ID: 35188632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals.
    Mekenyan O; Todorov M; Serafimova R; Stoeva S; Aptula A; Finking R; Jacob E
    Chem Res Toxicol; 2007 Dec; 20(12):1927-41. PubMed ID: 18052113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.